Vitros digoxin immunoassay evaluated for interference by digoxin-like immunoreactive factors

Clinical Chemistry

Volumn 44, Issue 6, 1998, Pages 1339-1340

  Way, Barbara A ^a   Wilhite, Timothy R ^b   Miller, Ralph ^b   Smith, Carl H ^a   Landt, Michael ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b BJC HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS LIKE FACTOR; DIGOXIN;

ANALYZER; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOASSAY;

EID: 14444281158     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.6.1339     Document Type: Article

References (7)

1. Jortani SA, Valdes R, Jr. Dioxin and its related endogenous factors. Clin Rev Clin Lab Sci 1997;34:225-74.
2. Stone JA, Soldin SJ. An update on digoxin. Clin Chem 1989;35:1326-31.
3. Valdes R Jr. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications. Clin Chem 1985;31:1525-32.
4. Pudek MR, Secombe DW, Whitfield MF, Ling E. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N Engl J Med 1983;308:904-5.
5. Jiang F, Wilhite TR, Smith CH, Landt M. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor. Ther Drug Monitor 1995;17:184-8.
6. Pudek MR, Secombe DW, Jacobson BE, Whitfield MF. Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clin Chem 1983;29:1972-4.
7. Datta P, Xu L, Malik S, Landicho D, Ferreri L, Halverson K, et al. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups. Clin Chem 1996;42:373-9.